Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Triple-negative breast cancer.

Literature DB >> 21067385

Triple-negative breast cancer.

William D Foulkes¹, Ian E Smith, Jorge S Reis-Filho.

Abstract

Triple-negative breast cancer, so called because it lacks expression of the estrogen receptor, progesterone receptor, and HER2, is often, but not always, a basal-like breast cancer. This review focuses on its origin, molecular and clinical characteristics, and treatment.

Entities: Disease Gene

Mesh：

Substances：

Year: 2010 PMID： 21067385 DOI： 10.1056/NEJMra1001389

Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245

Keyword Cloud
Cited

1474 in total

1. Prognosis in very young women with triple-negative breast cancer: retrospective study of 216 cases.

Authors: Ying Liu; Tao Xin; Da-yong Huang; Wei-xi Shen; Li Li; Yan-ju Lv; Ying-hua Jin; Xiao-wei Song; Chong Teng; Qiu-ying Jiang
Journal: Med Oncol Date: 2014-11-13 Impact factor: 3.064

2. CDDO-methyl ester delays breast cancer development in BRCA1-mutated mice.

Authors: Eun-Hee Kim; Chuxia Deng; Michael B Sporn; Darlene B Royce; Renee Risingsong; Charlotte R Williams; Karen T Liby
Journal: Cancer Prev Res (Phila) Date: 2011-09-20

3. Targeting an IKBKE cytokine network impairs triple-negative breast cancer growth.

Authors: Thanh U Barbie; Gabriela Alexe; Amir R Aref; Shunqiang Li; Zehua Zhu; Xiuli Zhang; Yu Imamura; Tran C Thai; Ying Huang; Michaela Bowden; John Herndon; Travis J Cohoon; Timothy Fleming; Pablo Tamayo; Jill P Mesirov; Shuji Ogino; Kwok-Kin Wong; Matthew J Ellis; William C Hahn; David A Barbie; William E Gillanders
Journal: J Clin Invest Date: 2014-11-03 Impact factor: 14.808

4. Blocking LLT1 (CLEC2D, OCIL)-NKRP1A (CD161) interaction enhances natural killer cell-mediated lysis of triple-negative breast cancer cells.

Authors: Armando M Marrufo; Stephen O Mathew; Pankaj Chaudhary; Joseph D Malaer; Jamboor K Vishwanatha; Porunelloor A Mathew
Journal: Am J Cancer Res Date: 2018-06-01 Impact factor: 6.166

5. A common Chk1-dependent phenotype of DNA double-strand break suppression in two distinct radioresistant cancer types.

Authors: Patrick H Dinkelborg; Meng Wang; Liliana Gheorghiu; Joseph M Gurski; Theodore S Hong; Cyril H Benes; Dejan Juric; Rachel B Jimenez; Kerstin Borgmann; Henning Willers
Journal: Breast Cancer Res Treat Date: 2019-01-03 Impact factor: 4.872

6. Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer.

Authors: Kristen S Purrington; Susan Slager; Diana Eccles; Drakoulis Yannoukakos; Peter A Fasching; Penelope Miron; Jane Carpenter; Jenny Chang-Claude; Nicholas G Martin; Grant W Montgomery; Vessela Kristensen; Hoda Anton-Culver; Paul Goodfellow; William J Tapper; Sajjad Rafiq; Susan M Gerty; Lorraine Durcan; Irene Konstantopoulou; Florentia Fostira; Athanassios Vratimos; Paraskevi Apostolou; Irene Konstanta; Vassiliki Kotoula; Sotiris Lakis; Meletios A Dimopoulos; Dimosthenis Skarlos; Dimitrios Pectasides; George Fountzilas; Matthias W Beckmann; Alexander Hein; Matthias Ruebner; Arif B Ekici; Arndt Hartmann; Ruediger Schulz-Wendtland; Stefan P Renner; Wolfgang Janni; Brigitte Rack; Christoph Scholz; Julia Neugebauer; Ulrich Andergassen; Michael P Lux; Lothar Haeberle; Christine Clarke; Nirmala Pathmanathan; Anja Rudolph; Dieter Flesch-Janys; Stefan Nickels; Janet E Olson; James N Ingle; Curtis Olswold; Seth Slettedahl; Jeanette E Eckel-Passow; S Keith Anderson; Daniel W Visscher; Victoria L Cafourek; Hugues Sicotte; Naresh Prodduturi; Elisabete Weiderpass; Leslie Bernstein; Argyrios Ziogas; Jennifer Ivanovich; Graham G Giles; Laura Baglietto; Melissa Southey; Veli-Matti Kosma; Hans-Peter Fischer; Malcom W R Reed; Simon S Cross; Sandra Deming-Halverson; Martha Shrubsole; Qiuyin Cai; Xiao-Ou Shu; Mary Daly; Joellen Weaver; Eric Ross; Jennifer Klemp; Priyanka Sharma; Diana Torres; Thomas Rüdiger; Heidrun Wölfing; Hans-Ulrich Ulmer; Asta Försti; Thaer Khoury; Shicha Kumar; Robert Pilarski; Charles L Shapiro; Dario Greco; Päivi Heikkilä; Kristiina Aittomäki; Carl Blomqvist; Astrid Irwanto; Jianjun Liu; Vernon Shane Pankratz; Xianshu Wang; Gianluca Severi; Arto Mannermaa; Douglas Easton; Per Hall; Hiltrud Brauch; Angela Cox; Wei Zheng; Andrew K Godwin; Ute Hamann; Christine Ambrosone; Amanda Ewart Toland; Heli Nevanlinna; Celine M Vachon; Fergus J Couch
Journal: Carcinogenesis Date: 2013-12-09 Impact factor: 4.944

Triple-negative breast cancer.

1. Prognosis in very young women with triple-negative breast cancer: retrospective study of 216 cases.

2. CDDO-methyl ester delays breast cancer development in BRCA1-mutated mice.

3. Targeting an IKBKE cytokine network impairs triple-negative breast cancer growth.

4. Blocking LLT1 (CLEC2D, OCIL)-NKRP1A (CD161) interaction enhances natural killer cell-mediated lysis of triple-negative breast cancer cells.

5. A common Chk1-dependent phenotype of DNA double-strand break suppression in two distinct radioresistant cancer types.

6. Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer.

Review 7. The use of nanoparticulates to treat breast cancer.

Review 8. Steroid hormone receptors as prognostic markers in breast cancer.

Review 9. Breast cancer in an 18-year-old female: A fatal case report and literature review.

10. PLAC1-specific TCR-engineered T cells mediate antigen-specific antitumor effects in breast cancer.